Robert P Baughman

Professor

Professional Summary

Dr. Baughman is Professor of Medicine at the University of Cincinnati. After completing undergraduate training at Yale University, he received his medical degree from Case Western Reserve School of Medicine. He joined the Internal Medicine staff at the University of Cincinnati after completing both an Internal Medicine residency and fellowship training in pulmonary diseases at the University of Cincinnati. His major research interests include two major clinic areas: the treatment of sarcoidosis and the diagnosis of pneumonia. Along with his long time collaborator Dr. Elyse Lower, he has developed several novel treatments for sarcoidosis, including methotrexate, thalidomide, leflunomide, and infliximab. Current studies include treatments for sarcoidosis associated fatigue and pulmonary hypertension due to sarcoidosis.

He is on the editorial board of multiple subspecialty journals, and his publications include over 150 original papers and over 70 review articles and/or book chapters. He is on the editorial board of several journals, including American Journal of Respiratory and Critical Care Medicine and Chest. In addition, Dr. Baughman is the recent editor of books on sarcoidosis, interstitial lung disease, and ventilator associated pneumonia.

Education

BS, Yale University 1973

MD, Case-Western Reserve 1977

Positions and Work Experience

1983 -1990 Assistant Professor, University of Cincinnati, Cincinnati, OH

1990 -1997 Associate Professor, University of Cincinnati, Cincinnati, OH

1997 -To Present Professor of Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH

Research and Practice Interests

Caseswill also be followed to gain information on the natural history of thisdisease including risk factors for progression of disease. A steeringcommittee will develop a protocol and manual of operations which willaddress the most promising hypotheses to be pursued to identify thecauses of sarcoidosis. The protocol will include a comprehensiveclinical characterization of each participant and determination of markersof immune responsiveness. The contractor will participate in a system forbanking biological specimens. A clinical coordinating center will be established to collect, manage andanalyze the data from the clinical centers. It is estimated that thetotal study population will consist of 720 cases and 1,440 controls. Itis estimated that each clinical center will enroll, interview, and examine72 cases age 21 years or older with sarcoidosis and, enroll, interviewand collect a blood specimen from 144 matched control subjects over a fouryear period. Clinical centers will 1 test specific hypotheses involvingrisk factors, familial aggregation, and genetics of the etiology of thisdisease and 2 describe the natural history of sarcoidosis. A six yearschedule is envisioned as follows: Phase I 12 Months: A collaborativeprotocol and manual of operations will be developed; Phase II 48 Months: will involve the recruitment and follow-up of patients and recruitment andinterviewing of control subjects, and Phase III 12 Months: will involvedata analysis.

Clinical Focus

Critical Care Medicine

Pulmonary Disease

Specialities

Critical Care Medicine

Internal Medicine

Certifications

American Board of Internal Medicine

09/09/1980

American Board of Internal Medicine (Pulmonary Disease)

11/09/1982

Research Support

Grant: #CHMC 333 / HL 072987 Investigators:Baughman, Robert 08-06-2003 -07-31-2007 National Heart, Lung and Blood Institute Mechanisms: IL-13 Induced Mucus Hypersecretion in Asthma Role:PI $242,095.00 Closed Level:Federal

Grant: #3-N01-HR-56069-06-A0-S1-E1 Investigators:Baughman, Robert 07-17-1995 -05-16-2002 National Heart, Lung and Blood Institute Clinical Centers for Etiology of Sarcoidosis: A Case Control Study Role:PI $587,685.00 Closed Level:Federal

Grant: #5-U01-HL-60263-05-A0-S0-E0 Investigators:Baughman, Robert 05-15-1999 -04-30-2004 National Heart, Lung and Blood Institute Sarcoidosis Genetic Linkage Consortium Role:PI $383,119.00 Closed Level:Federal

Grant: #VUMC 42525 / R01 HL117074 Investigators:Baughman, Robert; Shipley, Ralph 08-16-2013 -06-30-2018 National Heart, Lung and Blood Institute Microbial induction of sarcoidosis CD4+ T cell dysfunction Role:PI $100,866.00 Active Level:Federal

Grant: #Clin. Studies Network Investigators:Baughman, Robert 04-01-2015 -03-31-2017 Foundation for Sarcoidosis Research Defining Minimal Clinical Important Difference in Treatment Trials of Pulmonary Sarcoidosis Role:PI $30,000.00 Awarded Level:Private Non-Profit

Grant: #VUMV 42525 / R01 HL117074 Investigators:Baughman, Robert; Shipley, Ralph 07-01-2016 -06-30-2018 National Heart, Lung and Blood Institute Microbial induction of sarcoidosis CD4+ T cell dysfunction Role:PI $111,840.00 Active Level:Federal

Grant: #Clinical Trial Agreement - PAPLAND Investigators:Baughman, Robert; Lower, Elyse 11-26-2018 -11-25-2020 Foundation for Sarcoidosis Research Validation of a Sarcoidosis Diagnostic Score (SDS) Role:PI $80,000.00 Awarded Level:Private Non-Profit

Grant: #Check 3150 Investigators:Baughman, Robert 06-01-2019 -05-31-2021 Foundation for Sarcoidosis Research Foundation for Sarcoidosis Research addt'l network funding Role:PI $20,000.00 Awarded Level:Private Non-Profit

Honors and Awards

Alpha Omega Alpha - Case-Western Reserve

Richard W. Vilter Faculty Teaching Award 1986 and 1991

1999 -2005 Marquis Who's Who in America

2002 -2008 Best Doctors in America

Post Graduate Training and Education

1977-1980 Internship and Residency, University of Cincinnati, , Cincinnati, OH

1980-1982 Fellowship, Pulmonary, University of Cincinnati, , Cincinnati, OH

1982-1983 Chief Resident, Department of Internal Medicine, University of Cincinnati, , Cincinnati, OH

Keywords

Handbook,Immunity,Biomarker,Sarcoidosis,Case History,Human Subject,Clinical Trial,Data Collection,Family Genetics,Information System,Pathologic Process,Disease Proneness Risk,Patient Care Management,Longitudinal Human Study,Tissue Resource Registry

Contact Information

Academic - University of Cincinnat Medical Center- Homes, Room 1001
PO Box 670565
CincinnatiĀ  Ohio, 45267-0565
Phone: 513-584-5224
Fax: 513-584-5110
Bob.Baughman@uc.edu